Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic miceSylvaine You, Cyndi Chen, Wen-Hui Lee, et al.Molecular Imaging|December 7, 2007
Image-guided analyses reveal that non-CD4 splenocytes contribute to CD4+ T cell-mediated inflammation leading to islet destruction by altering their local function and not systemic trafficking patternsMi-Heon Lee, Wen-Hui Lee, Yanghao Van, et al.Experimental Biology and Medicine (Maywood, N.J.)|December 4, 2010
Comparative analyses of differentially induced T-cell receptor-mediated phosphorylation pathways in T lymphoma cellsSerina Ortiz, Wenhui Lee, David Smith, et al.Experimental Hematology|April 21, 2009
Mesenchymal stem cells suppress B-cell terminal differentiationSadaki Asari, Shin Itakura, Kevin Ferreri, et al.Viral Immunology|April 2, 2005
Maintenance of CD8+ T cells during acute viral infection of the central nervous system requires CD4+ T cells but not interleukin-2Jiehao Zhou, David R Hinton, Stephen A Stohlman, et al.Diabetes|November 6, 2008
All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cellsYang-Hau Van, Wen-Hui Lee, Serina Ortiz, et al.Plos One|February 15, 2013
Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individualsWeiting Du, Yueh-Wei Shen, Wen-Hui Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|January 20, 2011
Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cellsHanjun Qin, Zunde Wang, Weiting Du, et al.Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cellsDing Wang, Hanjun Qin, Weiting Du, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptidesSylvaine You, Cyndi Chen, Wen-Hui Lee, et al.Pageof 3